JOHN VIERLING to Chronic Disease
This is a "connection" page, showing publications JOHN VIERLING has written about Chronic Disease.
Connection Strength
0.149
-
Chronic Liver Allograft Rejection: Histopathological Insights and Future Directions. Results Probl Cell Differ. 2026; 77:251-273.
Score: 0.044
-
Immunology of acute and chronic hepatic allograft rejection. Liver Transpl Surg. 1999 Jul; 5(4 Suppl 1):S1-S20.
Score: 0.028
-
Immune disorders of the liver and bile duct. Gastroenterol Clin North Am. 1992 Jun; 21(2):427-49.
Score: 0.017
-
Suppressor function of liver mononuclear cells isolated during murine chronic graft-vs-host disease. II. Role of prostaglandins and interferon-gamma. Cell Immunol. 1992 Mar; 140(1):54-66.
Score: 0.017
-
Suppressor function of hepatic mononuclear inflammatory cells during murine chronic graft-vs-host disease. I. Macrophage-enriched cells mediate suppression in the liver. Cell Immunol. 1991 Jan; 132(1):256-68.
Score: 0.016
-
Hepatic homing of mononuclear inflammatory cells isolated during murine chronic graft-vs-host disease. J Immunol. 1989 Jul 15; 143(2):476-83.
Score: 0.014
-
In vitro cell-mediated cytotoxicity in primary biliary cirrhosis and chronic hepatitis. Dysfunction of spontaneous cell-mediated cytotoxicity in primary biliary cirrhosis. J Clin Invest. 1977 Nov; 60(5):1116-28.
Score: 0.006
-
Tacrolimus (FK 506) for rescue of chronic rejection following orthotopic liver transplantation. Transplant Proc. 1996 Apr; 28(2):1011-3.
Score: 0.006
-
Receptor specific clearance by the reticuloendothelial system in chronic liver diseases. Demonstration of defective C3b-specific clearance in primary biliary cirrhosis. J Clin Invest. 1978 Nov; 62(5):1069-77.
Score: 0.002